Empirical Finance’s Celgene Corp CELG Stock Holding History

Empirical Finance’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-358	Closed	-$42K	–	695
2016 Q4	$42K	Buy	+358	New	+$39.9K	0.03%	121

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Empirical Finance's CELG Position: Q1 2017 in Review

Empirical Finance sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 358 shares — an estimated $42K sold.

Empirical Finance first reported a position in CELG in Q4 2016 and held it in 1 quarter. The position peaked at $42K in Q4 2016. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

Empirical Finance reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
Empirical Finance sold 358 Celgene Corp shares in Q1 2017, an estimated $42K.
Empirical Finance first reported a position in Celgene Corp in Q4 2016 and held it in 1 quarter.
Empirical Finance's Celgene Corp position peaked at $42K in Q4 2016.
1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Empirical Finance's 13F filing for Q1 2017, filed 11 May 2017.